These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 10030437)
21. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study. Manitpisitkul P; Shalayda K; Todd M; Wang SS; Ness S; Ford L Epilepsia; 2013 Jan; 54(1):156-64. PubMed ID: 23157581 [TBL] [Abstract][Full Text] [Related]
22. Topiramate monotherapy in epilepsy and migraine prevention. Silberstein SD; Ben-Menachem E; Shank RP; Wiegand F Clin Ther; 2005 Feb; 27(2):154-65. PubMed ID: 15811478 [TBL] [Abstract][Full Text] [Related]
24. Topiramate: a new antiepileptic drug. Markind JE Am J Health Syst Pharm; 1998 Mar; 55(6):554-62. PubMed ID: 9544331 [TBL] [Abstract][Full Text] [Related]
25. Long-term efficacy and tolerability of topiramate as add-on therapy in refractory partial epilepsy: an observational study. Cho YJ; Heo K; Kim WJ; Jang SH; Jung YH; Ye BS; Song DB; Lee BI Epilepsia; 2009 Aug; 50(8):1910-9. PubMed ID: 19563348 [TBL] [Abstract][Full Text] [Related]
26. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group. Motte J; Trevathan E; Arvidsson JF; Barrera MN; Mullens EL; Manasco P N Engl J Med; 1997 Dec; 337(25):1807-12. PubMed ID: 9400037 [TBL] [Abstract][Full Text] [Related]
27. [The use of topiramate in the treatment of focal epilepsy in children]. Kremenchugskaia MR; Globa OV; Kuzenkova LM Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(12):33-8. PubMed ID: 24430032 [TBL] [Abstract][Full Text] [Related]
28. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080 [TBL] [Abstract][Full Text] [Related]
29. Topiramate use in pediatric patients. Glauser TA Can J Neurol Sci; 1998 Aug; 25(3):S8-12. PubMed ID: 9706734 [TBL] [Abstract][Full Text] [Related]
30. Short-term efficacy and tolerability of rufinamide adjunctive therapy in children with refractory generalised epilepsy. Kim SH; Lee JH; Ryu HW; Lim BC; Chae JH; Choi JE; Hwang YS; Kim KJ Epileptic Disord; 2013 Mar; 15(1):49-54. PubMed ID: 23531645 [TBL] [Abstract][Full Text] [Related]
31. Topiramate: a new safe and effective antiepileptic. Gupta M; Rehman N; Bansal J; Mogre V J Indian Med Assoc; 2001 Aug; 99(8):449-50. PubMed ID: 11881861 [TBL] [Abstract][Full Text] [Related]
32. Oxcarbazepine in the treatment of epilepsy in children and adolescents with intellectual disability. Gaily E; Granström ML; Liukkonen E J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():41-5. PubMed ID: 10030431 [TBL] [Abstract][Full Text] [Related]
33. [Experience in combined topiramate therapy of drug-resistant epilepsy]. Karlov VA; Vlasov PN; Freĭdkova NV Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(7):21-6. PubMed ID: 12938650 [TBL] [Abstract][Full Text] [Related]
34. Topiramate in children and adolescents with epilepsy and mental retardation: a prospective study on behavior and cognitive effects. Coppola G; Verrotti A; Resicato G; Ferrarelli S; Auricchio G; Operto FF; Pascotto A Epilepsy Behav; 2008 Feb; 12(2):253-6. PubMed ID: 17962081 [TBL] [Abstract][Full Text] [Related]
35. Topiramate monotherapy in adults with newly diagnosed epilepsy. Salinas-estabane R Adv Ther; 2002; 19(3):126-8. PubMed ID: 12201353 [TBL] [Abstract][Full Text] [Related]